308 related articles for article (PubMed ID: 21521264)
21. Intranasal delivery of Natesto® testosterone gel and its effects on doping markers.
Miller GD; Nair V; Morrison MS; Summers M; Willick SE; Eichner D
Drug Test Anal; 2016 Nov; 8(11-12):1197-1203. PubMed ID: 27714988
[TBL] [Abstract][Full Text] [Related]
22. Longitudinal evaluation of multiple biomarkers for the detection of testosterone gel administration in women with normal menstrual cycle.
Salamin O; Nicoli R; Langer T; Boccard J; Grundisch CS; Xu C; Rudaz S; Kuuranne T; Pitteloud N; Saugy M
Drug Test Anal; 2022 May; 14(5):833-850. PubMed ID: 33817997
[TBL] [Abstract][Full Text] [Related]
23. Dose-dependent testosterone sensitivity of the steroidal passport and GC-C-IRMS analysis in relation to the UGT2B17 deletion polymorphism.
Strahm E; Mullen JE; Gårevik N; Ericsson M; Schulze JJ; Rane A; Ekström L
Drug Test Anal; 2015; 7(11-12):1063-70. PubMed ID: 26198073
[TBL] [Abstract][Full Text] [Related]
24. Changes in blood parameters after intramuscular testosterone ester injections - Implications for anti-doping.
Solheim SA; Mørkeberg J; Dehnes Y; Hullstein I; Juul A; Upners EN; Nordsborg NB
Drug Test Anal; 2020 Aug; 12(8):1019-1030. PubMed ID: 32307878
[TBL] [Abstract][Full Text] [Related]
25. Impact of hormonal contraceptives on urinary steroid profile in relation to serum hormone changes and CYP17A1 polymorphism.
Ekström L; Knutsson JE; Mullen J; Ericsson M; Hirschberg AL
Drug Test Anal; 2019 Sep; 11(9):1284-1289. PubMed ID: 31207124
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of blood steroidal passport markers for detecting testosterone abuse in Asians.
Okano M; Shiomura S
Drug Test Anal; 2024 Jun; 16(6):595-603. PubMed ID: 37848395
[TBL] [Abstract][Full Text] [Related]
27. Screening for testosterone abuse in male athletes using the measurement of urinary LH, a revision of the paradigm.
Goebel C; Howe CJ; Ho KK; Nelson A; Kazlauskas R; Trout GJ
Drug Test Anal; 2009 Nov; 1(11-12):511-7. PubMed ID: 20355166
[TBL] [Abstract][Full Text] [Related]
28. Statistical discrimination of steroid profiles in doping control with support vector machines.
Van Renterghem P; Sottas PE; Saugy M; Van Eenoo P
Anal Chim Acta; 2013 Mar; 768():41-8. PubMed ID: 23473248
[TBL] [Abstract][Full Text] [Related]
29. Urinary and serum hormones profiles after testosterone enanthate administration in male hypogonadism: concerns on the detection of doping with testosterone in treated hypogonadal athletes.
Di Luigi L; Sgrò P; Romanelli F; Mazzarino M; Donati F; Braganò MC; Bianchini S; Fierro V; Casasco M; Botrè F; Lenzi A
J Endocrinol Invest; 2009 May; 32(5):445-53. PubMed ID: 19461217
[TBL] [Abstract][Full Text] [Related]
30. Reference ranges for the urinary steroid profile in a Latin-American population.
Martínez-Brito D; Correa Vidal MT; de la Torre X; García-Mir V; Ledea Lozano O; Granda Fraga M
Drug Test Anal; 2013 Aug; 5(8):619-26. PubMed ID: 23339119
[TBL] [Abstract][Full Text] [Related]
31. Codeine influences the serum and urinary profile of endogenous androgens but does not interact with the excretion rate of administered testosterone.
Lehtihet M; Andersson A; Börjesson A; Schulze J; Rane A; Ericsson M; Ekström L
Drug Test Anal; 2018 Apr; 10(4):723-730. PubMed ID: 28901724
[TBL] [Abstract][Full Text] [Related]
32. Detection of dihydrotestosterone gel, oral dehydroepiandrosterone, and testosterone gel misuse through the quantification of testosterone metabolites released after alkaline treatment.
Fabregat A; Pozo OJ; Van Renterghem P; Van Eenoo P; Marcos J; Segura J; Ventura R
Drug Test Anal; 2011; 3(11-12):828-35. PubMed ID: 21998068
[TBL] [Abstract][Full Text] [Related]
33. Long-term administration of testosterone enanthate to normal men: alterations of the urinary profile of androgen metabolites potentially useful for detection of testosterone misuse in sport.
Dehennin L; Matsumoto AM
J Steroid Biochem Mol Biol; 1993 Feb; 44(2):179-89. PubMed ID: 8439522
[TBL] [Abstract][Full Text] [Related]
34. Bayesian detection of abnormal values in longitudinal biomarkers with an application to T/E ratio.
Sottas PE; Baume N; Saudan C; Schweizer C; Kamber M; Saugy M
Biostatistics; 2007 Apr; 8(2):285-96. PubMed ID: 16785250
[TBL] [Abstract][Full Text] [Related]
35. Sensitivity of doping biomarkers after administration of a single dose testosterone gel.
Mullen J; Börjesson A; Hopcraft O; Schulze JJ; Ericsson M; Rane A; Lehtihet M; Ekström L
Drug Test Anal; 2018 May; 10(5):839-848. PubMed ID: 29150907
[TBL] [Abstract][Full Text] [Related]
36. Influence of multiple human chorionic gonadotropin administrations on serum and urinary steroid Athlete Biological Passport profiles in males.
Goodrum JM; Moore C; Crouch AK; Eichner D; Miller GD
Drug Test Anal; 2023; 15(11-12):1371-1381. PubMed ID: 37749856
[TBL] [Abstract][Full Text] [Related]
37. Discordant genotyping results using DNA isolated from anti-doping control urine samples.
Choong E; Schulze JJ; Ericsson M; Rane A; Ekström L
Drug Test Anal; 2017 Jul; 9(7):994-1000. PubMed ID: 27706926
[TBL] [Abstract][Full Text] [Related]
38. Alternative markers for the long-term detection of oral testosterone misuse.
Fabregat A; Pozo OJ; Marcos J; Segura J; Ventura R
Steroids; 2011 Nov; 76(12):1367-76. PubMed ID: 21782838
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of markers out of the steroid profile for the screening of testosterone misuse. Part I: Transdermal administration.
Kotronoulas A; Gomez-Gómez À; Fabregat A; Segura J; Yang S; Xing Y; Moutian W; Marcos J; Joglar J; Ventura R; Pozo OJ
Drug Test Anal; 2018 May; 10(5):821-831. PubMed ID: 29148228
[TBL] [Abstract][Full Text] [Related]
40. Studies of athlete biological passport biomarkers and clinical parameters in male and female users of anabolic androgenic steroids and other doping agents.
Börjesson A; Lehtihet M; Andersson A; Dahl ML; Vicente V; Ericsson M; Ekström L
Drug Test Anal; 2020 Apr; 12(4):514-523. PubMed ID: 31925932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
